412
Views
66
CrossRef citations to date
0
Altmetric
Review

Stimuli-responsive graphene-incorporated multifunctional chitosan for drug delivery applications: a review

, ORCID Icon & ORCID Icon
Pages 79-99 | Received 14 Aug 2018, Accepted 03 Dec 2018, Published online: 21 Dec 2018

References

  • Mainardes RM, Silva LP. Drug delivery systems: past, present, and future. Curr Drug Targets. 2004;5:449–455.
  • Reddy PD, Swarnalatha D. Recent advances in novel drug delivery systems. Int J Pharmtech Res. 2010;2:2025–2027.
  • Arora S, Ali J, Ahuja A, et al. Floating drug delivery systems: a review. Aaps PharmSciTech. 2005;6:E372–E90.
  • Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153:198.
  • Bruschi M L. Development of drug delivery systems and quality by design. Recent Pat Drug Deliv Formul. 2015;9:105.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Marcucci F, Lefoulon F. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress. Drug Discov Today. 2004;9:219–228.
  • Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86:215–223.
  • Maderuelo C, Zarzuelo A, Lanao JM. Critical factors in the release of drugs from sustained release hydrophilic matrices. J Control Release. 2011;154:2–19.
  • Saks SR, Gardner LB. The pharmacoeconomic value of controlled-release dosage forms. J Control Release. 1997;48:237–242.
  • Langer R. Polymer-controlled drug delivery systems. Acc Chem Res. 1993;26:537–542.
  • Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv. 2007;4:297–305.
  • Nanjwade BK, Bechra HM, Derkar GK, et al. Dendrimers: emerging polymers for drug-delivery systems. Eur J Pharm Sci. 2009;38:185–196.
  • Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res. 2006;67:55–60.
  • Liu Z, Robinson JT, Tabakman SM, et al. Carbon materials for drug delivery & cancer therapy. Mater Today. 2011;14:316–323.
  • Bernkop-Schnürch A, Dünnhaupt S. Chitosan-based drug delivery systems. Eur J Pharm Biopharm. 2012;81:463–469.
  • Saneja A, Nehate C, Alam N, et al. Recent advances in chitosan-based nanomedicines for cancer chemotherapy. In: Dutta PK, editor. Chitin and chitosan for regenerative medicine. Springer Series on Polymer and Composite Materials. New Delhi: Springer; 2016. p. 229–259.
  • Zhu Y, Murali S, Cai W, et al. Graphene and graphene oxide: synthesis, properties, and applications. Adv Mater. 2010;22:3906–3924.
  • Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9:9243–9257.
  • Dutta PK, Dutta J, Tripathi V Chitin and chitosan: Chemistry, properties and applications. J Sci Ind Res. 2004;63:20–31.
  • Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci. 2006;31:603–632.
  • Dash M, Chiellini F, Ottenbrite R, et al. Chitosan—A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36:981–1014.
  • Kumar MR, Muzzarelli RA, Muzzarelli C, et al. Chitosan chemistry and pharmaceutical perspectives. Chem Rev. 2004;104:6017–6084.
  • Prabaharan M. Chitosan derivatives as promising materials for controlled drug delivery. J Biomater Appl. 2008;23:5–36.
  • Elgadir MA, Uddin MS, Ferdosh S, et al. Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review. J Food Drug Anal. 2015;23:619–629.
  • Dutta PK, Dutta J, editors. Multifaceted development and application of biopolymers for biology, biomedicine and nanotechnology. Heidelberg: Springer; 2013.
  • Semwal A, Singh R, Dutta P. Chitosan: a promising substrate for pharmaceuticals. J Chitin Chitosan Sci. 2013;1:87–102.
  • Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010;62:3–11.
  • Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol. 2010;56:290–299.
  • Kashyap M, Archana D, Semwal A, et al. Chitosan: a promising substrate for regenerative medicine in drug formulation. In: Dutta PK, editor. Chitin and chitosan for regenerative medicine. Springer Series on Polymer and Composite Materials. New Delhi: Springer; 2016. p. 261–277.
  • Shu X, Zhu K, Song W. Novel pH-sensitive citrate cross-linked chitosan film for drug controlled release. Int J Pharm. 2001;212:19–28.
  • Puttipipatkhachorn S, Nunthanid J, Yamamoto K, et al. Drug physical state and drug–polymer interaction on drug release from chitosan matrix films. J Control Release. 2001;75:143–153.
  • Kistriyani L, Sulistyawan W, Kesuma SH. Characteristic of ascorbic acid in crosslinked chitosan edible film as drug delivery system membrane. MATEC Web of Conferences: EDP Sciences. 2018;01027.
  • Mi FL, Her NL, Kuan CY, et al. Chitosan tablets for controlled release of theophylline: effect of polymer—drug wet or dry blending and anionic—cationic interpolymer complex. J Appl Polym Sci. 1997;66:2495–2505.
  • Sogias IA, Williams AC, Khutoryanskiy VV. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen. Int J Pharm. 2012;436:602–610.
  • Sahasathian T, Kerdcholpetch T, Chanweroch A, et al. Sustained release of amoxicillin from chitosan tablets. Arch Pharm Res. 2007;30:526–531.
  • Millotti G, Laffleur F, Perera G, et al. In vivo evaluation of thiolated chitosan tablets for oral insulin delivery. J Pharm Sci. 2014;103:3165–3170.
  • Tozaki H, Odoriba T, Okada N, et al. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Release. 2002;82:51–61.
  • Tozaki H, Komoike J, Tada C, et al. Chitosan capsules for colon‐specific drug delivery: improvement of insulin absorption from the rat colon. J Pharm Sci. 1997;86:1016–1021.
  • Tozaki H, Fujita T, Odoriba T, et al. Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2, 4, 6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. Life Sci. 1999;64:1155–1162.
  • Mitra S, Gaur U, Ghosh P, et al. Tumour targeted delivery of encapsulated dextran–doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release. 2001;74:317–323.
  • De Campos AM, Sánchez A, Alonso M. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224:159–168.
  • Janes KA, Fresneau MP, Marazuela A, et al. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release. 2001;73:255–267.
  • Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials. 2009;30:5691–5700.
  • Aydin R, Pulat M. 5-Fluorouracil encapsulated chitosan nanoparticles for pH-stimulated drug delivery: evaluation of controlled release kinetics. J Nanomater. 2012;2012:42.
  • Bugamelli F, Raggi MA, Orienti I, et al. Controlled insulin release from chitosan microparticles. Arch Pharm. 1998;331:133–138.
  • Yang C-H, Huang K-S, Chang J-Y. Manufacturing monodisperse chitosan microparticles containing ampicillin using a microchannel chip. Biomed Microdevices. 2007;9:253–259.
  • Novoselov KS, Geim AK, Morozov SV, et al. Electric field effect in atomically thin carbon films. Science. 2004;306:666–669.
  • Kumar A, Husale S, Srivastava A, et al. Cu–ni nanoparticle-decorated graphene based photodetector. Nanoscale. 2014;6:8192–8198.
  • Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM, et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials. 2011;32:1121–1129.
  • Hummers WS Jr, Offeman RE. Preparation of graphitic oxide. J Am Chem Soc. 1958;80:1339.
  • Zhang L, Xia J, Zhao Q, et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010;6:537–544.
  • Gui D, Liu C, Chen F, et al. Preparation of polyaniline/graphene oxide nanocomposite for the application of supercapacitor. Appl Surf Sci. 2014;307:172–177.
  • Cong H-P, Ren X-C, Wang P, et al. Flexible graphene–polyaniline composite paper for high-performance supercapacitor. Energy Environ Sci. 2013;6:1185–1191.
  • Wu Q, Xu Y, Yao Z, et al. Supercapacitors based on flexible graphene/polyaniline nanofiber composite films. ACS Nano. 2010;4:1963–1970.
  • Zhang Q, Li Y, Feng Y, et al. Electropolymerization of graphene oxide/polyaniline composite for high-performance supercapacitor. Electrochim Acta. 2013;90:95–100.
  • Al-Mashat L, Shin K, Kalantar-Zadeh K, et al. Graphene/polyaniline nanocomposite for hydrogen sensing. J Phys Chem C. 2010;114:16168–16173.
  • Wu Z, Chen X, Zhu S, et al. Enhanced sensitivity of ammonia sensor using graphene/polyaniline nanocomposite. Sens Actuators B Chem. 2013;178:485–493.
  • Huang X, Hu N, Gao R, et al. Reduced graphene oxide–polyaniline hybrid: preparation, characterization and its applications for ammonia gas sensing. J Mater Chem. 2012;22:22488–22495.
  • Ruecha N, Rodthongkum N, Cate DM, et al. Sensitive electrochemical sensor using a graphene–polyaniline nanocomposite for simultaneous detection of Zn (II), Cd (II), and Pb (II). Anal Chim Acta. 2015;874:40–48.
  • Konwer S, Guha AK, Dolui SK. Graphene oxide-filled conducting polyaniline composites as methanol-sensing materials. J Mater Sci. 2013;48:1729–1739.
  • Bo Y, Yang H, Hu Y, et al. A novel electrochemical DNA biosensor based on graphene and polyaniline nanowires. Electrochim Acta. 2011;56:2676–2681.
  • Zheng Q, Wu H, Shen Z, et al. An electrochemical DNA sensor based on polyaniline/graphene: high sensitivity to DNA sequences in a wide range. Analyst. 2015;140:6660–6670.
  • Li R, Liu L, Yang F. Preparation of polyaniline/reduced graphene oxide nanocomposite and its application in adsorption of aqueous Hg (II). Chem Eng J. 2013;229:460–468.
  • Lim M-Y, Shin H, Shin DM, et al. Poly (vinyl alcohol) nanocomposites containing reduced graphene oxide coated with tannic acid for humidity sensor. Polymer. 2016;84:89–98.
  • Baruah U, Chowdhury D. Functionalized graphene oxide quantum dot–PVA hydrogel: a colorimetric sensor for Fe2+, Co2+ and Cu2+ ions. Nanotechnology. 2016;27:145501.
  • Zhu H, Du M, Zhang M, et al. Facile and green fabrication of small, mono-disperse and size-controlled noble metal nanoparticles embedded in water-stable polyvinyl alcohol nanofibers: high sensitive, flexible and reliable materials for biosensors. Sens Actuators B Chem. 2013;185:608–619.
  • Qi Y, Tai Z, Sun D, et al. Fabrication and characterization of poly (vinyl alcohol)/graphene oxide nanofibrous biocomposite scaffolds. J Appl Polym Sci. 2013;127:1885–1894.
  • Li J, Guo S, Zhai Y, et al. High-sensitivity determination of lead and cadmium based on the Nafion-graphene composite film. Anal Chim Acta. 2009;649:196–201.
  • Jia L-P, Wang H-S. Preparation and application of a highly sensitive nonenzymatic ethanol sensor based on nickel nanoparticles/Nafion/graphene composite film. Sens Actuators B Chem. 2013;177:1035–1042.
  • Li J, Guo S, Zhai Y, et al. Nafion–graphene nanocomposite film as enhanced sensing platform for ultrasensitive determination of cadmium. Electrochem Commun. 2009;11:1085–1088.
  • Lu L-M, Li H-B, Qu F, et al. In situ synthesis of palladium nanoparticle–graphene nanohybrids and their application in nonenzymatic glucose biosensors. Biosens Bioelectron. 2011;26:3500–3504.
  • Wu P, Shao Q, Hu Y, et al. Direct electrochemistry of glucose oxidase assembled on graphene and application to glucose detection. Electrochim Acta. 2010;55:8606–8614.
  • Zhang W, Guo Z, Huang D, et al. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011;32:8555–8561.
  • Wen H, Dong C, Dong H, et al. Engineered redox‐responsive PEG detachment mechanism in PEGylated nano‐graphene oxide for intracellular drug delivery. Small. 2012;8:760–769.
  • Shen H, Liu M, He H, et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl Mater Interfaces. 2012;4:6317–6323.
  • Xu H, Fan M, Elhissi AM, et al. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Nanomedicine. 2015;10:1247–1262.
  • Wang C, Feng L, Yang H, et al. Graphene oxide stabilized polyethylene glycol for heat storage. Phys Chem Chem Phys. 2012;14:13233–13238.
  • Qi G-Q, Liang C-L, Bao R-Y, et al. Polyethylene glycol based shape-stabilized phase change material for thermal energy storage with ultra-low content of graphene oxide. Sol Energy Mater Sol Cells. 2014;123:171–177.
  • Qi G-Q, Yang J, Bao R-Y, et al. Enhanced comprehensive performance of polyethylene glycol based phase change material with hybrid graphene nanomaterials for thermal energy storage. Carbon. 2015;88:196–205.
  • Liu Y, Zhou J, Tang J, et al. Three-dimensional, chemically bonded polypyrrole/bacterial cellulose/graphene composites for high-performance supercapacitors. Chem Mater. 2015;27:7034–7041.
  • Weng Z, Su Y, Wang DW, et al. Graphene–cellulose paper flexible supercapacitors. Adv Energy Mater. 2011;1:917–922.
  • Kafy A, Akther A, Zhai L, et al. Porous cellulose/graphene oxide nanocomposite as flexible and renewable electrode material for supercapacitor. Synth Met. 2017;223:94–100.
  • Kafy A, Sadasivuni KK, Akther A, et al. Cellulose/graphene nanocomposite as multifunctional electronic and solvent sensor material. Mater Lett. 2015;159:20–23.
  • Sadasivuni KK, Kafy A, Zhai L, et al. Transparent and flexible cellulose nanocrystal/reduced graphene oxide film for proximity sensing. Small. 2015;11:994–1002.
  • Sadasivuni KK, Kafy A, Kim H-C, et al. Reduced graphene oxide filled cellulose films for flexible temperature sensor application. Synth Met. 2015;206:154–161.
  • Yang J, Zhang E, Li X, et al. Cellulose/graphene aerogel supported phase change composites with high thermal conductivity and good shape stability for thermal energy storage. Carbon. 2016;98:50–57.
  • Kang Y-R, Li Y-L, Hou F, et al. Fabrication of electric papers of graphene nanosheet shelled cellulose fibres by dispersion and infiltration as flexible electrodes for energy storage. Nanoscale. 2012;4:3248–3253.
  • Rasoulzadeh M, Namazi H. Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent. Carbohydr Polym. 2017;168:320–326.
  • Luo H, Ao H, Li G, et al. Bacterial cellulose/graphene oxide nanocomposite as a novel drug delivery system. Curr Appl Phys. 2017;17:249–254.
  • Wu H, Wang J, Kang X, et al. Glucose biosensor based on immobilization of glucose oxidase in platinum nanoparticles/graphene/chitosan nanocomposite film. Talanta. 2009;80:403–406.
  • Yang J, Yu J-H, Strickler JR, et al. Nickel nanoparticle–chitosan-reduced graphene oxide-modified screen-printed electrodes for enzyme-free glucose sensing in portable microfluidic devices. Biosens Bioelectron. 2013;47:530–538.
  • Fan L, Luo C, Sun M, et al. Synthesis of magnetic β-cyclodextrin–chitosan/graphene oxide as nanoadsorbent and its application in dye adsorption and removal. Colloids Surf B Biointerfaces. 2013;103:601–607.
  • Li L, Luo C, Li X, et al. Preparation of magnetic ionic liquid/chitosan/graphene oxide composite and application for water treatment. Int J Biol Macromol. 2014;66:172–178.
  • Wang C, Chen B, Zou M, et al. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging. Colloids Surf B Biointerfaces. 2014;122:332–340.
  • Pan Q, Lv Y, Williams GR, et al. Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. Carbohydr Polym. 2016;151:812–820.
  • Chang Y, Yang S-T, Liu J-H, et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett. 2011;200:201–210.
  • Zhang X, Yin J, Peng C, et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration. Carbon. 2011;49:986–995.
  • Liao K-H, Lin Y-S, Macosko CW, et al. Cytotoxicity of graphene oxide and graphene in human erythrocytes and skin fibroblasts. ACS Appl Mater Interfaces. 2011;3:2607–2615.
  • Xu M, Zhu J, Wang F, et al. Improved in vitro and in vivo biocompatibility of graphene oxide through surface modification: poly (acrylic acid)-functionalization is superior to PEGylation. ACS Nano. 2016;10:3267–3281.
  • Yang K, Wan J, Zhang S, et al. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano. 2010;5:516–522.
  • Zhi X, Fang H, Bao C, et al. The immunotoxicity of graphene oxides and the effect of PVP-coating. Biomaterials. 2013;34:5254–5261.
  • Chen Y, Qi Y, Tai Z, et al. Preparation, mechanical properties and biocompatibility of graphene oxide/ultrahigh molecular weight polyethylene composites. Eur Polym J. 2012;48:1026–1033.
  • Liu Z, Robinson JT, Sun X, et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc. 2008;130:10876–10877.
  • Wang R, Shou D, Lv O, et al. pH-Controlled drug delivery with hybrid aerogel of chitosan, carboxymethyl cellulose and graphene oxide as the carrier. Int J Biol Macromol. 2017;103:248–253.
  • Stankovich S, Dikin DA, Dommett GH, et al. Graphene-based composite materials. Nature. 2006;442:282.
  • Pan Y, Wu T, Bao H, et al. Green fabrication of chitosan films reinforced with parallel aligned graphene oxide. Carbohydr Polym. 2011;83:1908–1915.
  • Depan D, Girase B, Shah J, et al. Structure–process–property relationship of the polar graphene oxide-mediated cellular response and stimulated growth of osteoblasts on hybrid chitosan network structure nanocomposite scaffolds. Acta Biomater. 2011;7:3432–3445.
  • Justin R, Chen B. Characterisation and drug release performance of biodegradable chitosan–graphene oxide nanocomposites. Carbohydr Polym. 2014;103:70–80.
  • Denet A-R, Vanbever R, Préat V. Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev. 2004;56:659–674.
  • Brown MB, Traynor MJ, Martin GP, et al. Transdermal drug delivery systems: skin perturbation devices. In: Jain KK, editor. Drug delivery systems. New York: Humana Press; 2008. p. 119–139.
  • Justin R, Chen B. Strong and conductive chitosan–reduced graphene oxide nanocomposites for transdermal drug delivery. J Mat Chem B. 2014;2:3759–3770.
  • Moore TL, Rodriguez-Lorenzo L, Hirsch V, et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev. 2015;44:6287–6305.
  • Zuo H, Gu Z, Cooper H, et al. Crosslinking to enhance colloidal stability and redispersity of layered double hydroxide nanoparticles. J Colloid Interface Sci. 2015;459:10–16.
  • Lee SH, Dreyer DR, An J, et al. Polymer brushes via controlled, surface‐initiated atom transfer radical polymerization (ATRP) from graphene oxide. Macromol Rapid Commun. 2010;31:281–288.
  • Yang K, Li Y, Tan X, et al. Behavior and toxicity of graphene and its functionalized derivatives in biological systems. Small. 2013;9:1492–1503.
  • Fang M, Long J, Zhao W, et al. pH-responsive chitosan-mediated graphene dispersions. Langmuir. 2010;26:16771–16774.
  • Yang H, Bremner DH, Tao L, et al. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Carbohydr Polym. 2016;135:72–78.
  • Bao H, Pan Y, Ping Y, et al. Chitosan‐functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 2011;7:1569–1578.
  • Zhang X, Hu W, Li J, et al. A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond. Toxicol Res (Camb). 2012;1:62–68.
  • An W, Zhang Y, Zhang X, et al. Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes. Experimental Eye Research. 2018;174:59–69.
  • Zhang H, Yan T, Xu S, et al. Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides. Mater Sci Eng C. 2017;73:144–151.
  • Hu H, Tang C, Yin C. Folate conjugated trimethyl chitosan/graphene oxide nanocomplexes as potential carriers for drug and gene delivery. Mater Lett. 2014;125:82–85.
  • Rana VK, Choi MC, Kong JY, et al. Synthesis and drug‐delivery behavior of chitosan‐functionalized graphene oxide hybrid nanosheets. Macromol Mater Eng. 2011;296:131–140.
  • Fan H, Wang L, Zhao K, et al. Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites. Biomacromolecules. 2010;11:2345–2351.
  • Gaharwar AK, Peppas NA, Khademhosseini A. Nanocomposite hydrogels for biomedical applications. Biotechnol Bioeng. 2014;111:441–453.
  • Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2012;64:18–23.
  • Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev. 2008;60:1638–1649.
  • Wichterle O, Lim D. Hydrophilic gels for biological use. Nature. 1960;185:117.
  • Mamaghani KR, Naghib SM, Zahedi A, et al. Synthesis and microstructural characterization of GelMa/PEGDA hybrid hydrogel containing graphene oxide for biomedical purposes. Mater Today Proc. 2018;5:15635–15644.
  • Kalkhoran AHZ, Vahidi O, Naghib SM. A new mathematical approach to predict the actual drug release from hydrogels. Eur J Pharm Sci. 2018;111:303–310.
  • Kalkhoran AHZ, Naghib SM, Vahidi O, et al. Synthesis and characterization of graphene-grafted gelatin nanocomposite hydrogels as emerging drug delivery systems. Biomed Phys Eng Express. 2018;4:055017.
  • Bhattarai N, Gunn J, Zhang M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev. 2010;62:83–99.
  • Chen K, Ling Y, Cao C, et al. Chitosan derivatives/reduced graphene oxide/alginate beads for small-molecule drug delivery. Mater Sci Eng C. 2016;69:1222–1228.
  • Bag DS, Saxena AK Smart gels. Kirk-Othmer Encyclopedia of Chemical Technology. Hoboken, NJ: John Wiley & Sons; 2014
  • Yu L, Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev. 2008;37:1473–1481.
  • Saeednia L, Yao L, Berndt M, et al. Structural and biological properties of thermosensitive chitosan–graphene hybrid hydrogels for sustained drug delivery applications. J Biomed Mater Res A. 2017;105:2381–2390.
  • Ulker Z, Erkey C. An emerging platform for drug delivery: aerogel based systems. J Control Release. 2014;177:51–63.
  • Chen Y, Qi Y, Yan X, et al. Green fabrication of porous chitosan/graphene oxide composite xerogels for drug delivery. J Appl Polym Sci. 2014;131:1–11.
  • Lin T, Zhang L, Davis J, et al. Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers. Mol Ther. 2003;8:441–448.
  • Yadav S, van Vlerken LE, Little SR, et al. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Cancer Chemother Pharmacol. 2009;63:711–722.
  • Gao X, Kim K-S, Liu D. Nonviral gene delivery: what we know and what is next. Aaps J. 2007;9:E92–E104.
  • Saad M, Garbuzenko OB, Minko T Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine. 2008;3:761–776.
  • Chen AM, Zhang M, Wei D, et al. Co‐delivery of doxorubicin and Bcl‐2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug‐resistant cancer cells. Small. 2009;5:2673–2677.
  • Wang C, Ravi S, Garapati US, et al. Multifunctional chitosan magnetic-graphene (CMG) nanoparticles: a theranostic platform for tumor-targeted co-delivery of drugs, genes and MRI contrast agents. J Mat Chem B. 2013;1:4396–4405.
  • Wang C, Zhang Z, Chen B, et al. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system. J Colloid Interface Sci. 2018;516:332–341.
  • Salehi R, Irani M, Rashidi M-R, et al. Stimuli-responsive nanofibers prepared from poly (N-isopropylacrylamide-acrylamide-vinylpyrrolidone) by electrospinning as an anticancer drug delivery. Des Monomers Polym. 2013;16:515–527.
  • Salehi R, Irani M, Eskandani M, et al. Interaction, controlled release, and antitumor activity of doxorubicin hydrochloride from pH-sensitive P (NIPAAm-MAA-VP) nanofibrous scaffolds prepared by green electrospinning. Int J Polym Mater Polym Biomater. 2014;63:609–619.
  • Anaraki NA, Rad LR, Irani M, et al. Fabrication of PLA/PEG/MWCNT electrospun nanofibrous scaffolds for anticancer drug delivery. J Appl Polym Sci. 2014;3:n/a–n/a.
  • Shalumon K, Anulekha K, Girish C, et al. Single step electrospinning of chitosan/poly (caprolactone) nanofibers using formic acid/acetone solvent mixture. Carbohydr Polym. 2010;80:413–419.
  • Ardeshirzadeh B, Anaraki NA, Irani M, et al. Controlled release of doxorubicin from electrospun PEO/chitosan/graphene oxide nanocomposite nanofibrous scaffolds. Mater Sci Eng C. 2015;48:384–390.
  • Siddiqui MN, Garg G, Sharma PK. A short review on “A novel approach in oral fast dissolving drug delivery system and their patents”. Adv Biol Res. 2011;5:291–303.
  • Moroz E, Matoori S, Leroux J-C. Oral delivery of macromolecular drugs: where we are after almost 100years of attempts. Adv Drug Deliv Rev. 2016;101:108–121.
  • Des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release. 2006;116:1–27.
  • Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–321.
  • Verma A, Kumar N, Malviya R, et al. Emerging trends in noninvasive insulin delivery. J Pharm (Cairo). 2014;2014.
  • Najafzadeh H, Kooshapur H, Kianidehkordi F. Evaluation of an oral insulin formulation in normal and diabetic rats. Indian J Pharmacol. 2012;44:103.
  • Mei L, Zhang Z, Zhao L, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65:880–890.
  • Thanki K, Gangwal RP, Sangamwar AT, et al. Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013;170:15–40.
  • Banna GL, Collovà E, Gebbia V, et al. Anticancer oral therapy: emerging related issues. Cancer Treat Rev. 2010;36:595–605.
  • Park K, Kwon IC, Park K. Oral protein delivery: current status and future prospect. React Funct Polym. 2011;71:280–287.
  • Renukuntla J, Vadlapudi AD, Patel A, et al. Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm. 2013;447:75–93.
  • Mansuri S, Kesharwani P, Jain K, et al. Mucoadhesion: a promising approach in drug delivery system. React Funct Polym. 2016;100:151–172.
  • Dodane V, Khan MA, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm. 1999;182:21–32.
  • Sonaje K, Chuang E-Y, Lin K-J, et al. Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations. Mol Pharm. 2012;9:1271–1279.
  • Yeh T-H, Hsu L-W, Tseng MT, et al. Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. Biomaterials. 2011;32:6164–6173.
  • Li L, Jiang G, Yu W, et al. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Mater Sci Eng C. 2017;70:278–286.
  • Smith J, Wood E, Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm Res. 2004;21:43–49.
  • Chen M-C, Mi F-L, Liao Z-X, et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules. Adv Drug Deliv Rev. 2013;65:865–879.
  • Al Rubeaan K, Rafiullah M, Jayavanth S. Oral insulin delivery systems using chitosan-based formulation: A review. Expert Opin Drug Deliv. 2016;13:223–237.
  • Abbad S, Zhang Z, Waddad AY, et al. Chitosan-modified cationic amino acid nanoparticles as a novel oral delivery system for insulin. J Biomed Nanotechnol. 2015;11:486–499.
  • He Z, Santos JL, Tian H, et al. Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin. Biomaterials. 2017;130:28–41.
  • Li J, Jiang C, Lang X, et al. Multilayer sodium alginate beads with porous core containing chitosan based nanoparticles for oral delivery of anticancer drug. Int J Biol Macromol. 2016;85:1–8.
  • Farhadian A, Dounighi NM, Avadi M. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery. Hum Vaccin Immunother. 2015;11:2811–2818.
  • Rahmanian N, Hamishehkar H, Dolatabadi JEN, et al. Nano graphene oxide: a novel carrier for oral delivery of flavonoids. Colloids Surf B Biointerfaces. 2014;123:331–338.
  • Hou L, Shi Y, Jiang G, et al. Smart nanocomposite hydrogels based on azo crosslinked graphene oxide for oral colon-specific drug delivery. Nanotechnology. 2016;27:315105.
  • Peng J-M, Lin J-C, Chen Z-Y, et al. Enhanced antimicrobial activities of silver-nanoparticle-decorated reduced graphene nanocomposites against oral pathogens. Mater Sci Eng C. 2017;71:10–16.
  • Yang K, Gong H, Shi X, et al. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials. 2013;34:2787–2795.
  • de Sousa IP, Buttenhauser K, Suchaoin W, et al. Thiolated graphene oxide as promising mucoadhesive carrier for hydrophobic drugs. Int J Pharm. 2016;509:360–367.
  • Javanabkht S, Shaabani A. Encapsulation of graphene quantum dot-crosslinked chitosan by carboxymethylcellulose hydrogel beads as a pH-responsive bio-nanocomposite for the oral delivery agent. Int J Biol Macromol. 2018;123:389–397.
  • Sangeetha S, Venkatesh DN, Krishan P, et al. Mucosa as a route for systemic drug delivery. Res J Pharm Biol Chem Sci. 2010;1:178–187.
  • Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release. 2004;100:5–28.
  • Du Toit LC, Pillay V, Choonara YE, et al. Ocular drug delivery–a look towards nanobioadhesives. Expert Opin Drug Deliv. 2011;8:71–94.
  • Zhang H, Oh M, Allen C, et al. Monodisperse chitosan nanoparticles for mucosal drug delivery. Biomacromolecules. 2004;5:2461–2468.
  • Issa MM, Köping-Höggård M, Artursson P. Chitosan and the mucosal delivery of biotechnology drugs. Drug Discov Today. 2005;2:1–6.
  • Gaudana R, Ananthula HK, Parenky A, et al. Ocular drug delivery. Aaps J. 2010;12:348–360.
  • Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today. 2008;13:144–151.
  • Başaran E, Yazan Y. Ocular application of chitosan. Expert Opin Drug Deliv. 2012;9:701–712.
  • Alonso MJ, Sánchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55:1451–1463.
  • Da Silva SB, Ferreira D, Pintado M, et al. Chitosan-based nanoparticles for rosmarinic acid ocular delivery—in vitro tests. Int J Biol Macromol. 2016;84:112–120.
  • Illum L. Nasal drug delivery—recent developments and future prospects. J Control Release. 2012;161:254–263.
  • Türker S, Onur E, Ózer Y. Nasal route and drug delivery systems. Pharm World Sci. 2004;26:137–142.
  • Ozsoy Y, Güngör S. Nasal route: an alternative approach for antiemetic drug delivery. Expert Opin Drug Deliv. 2011;8:1439–1453.
  • Luppi B, Bigucci F, Cerchiara T, et al. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles. Expert Opin Drug Deliv. 2010;7:811–828.
  • Casettari L, Illum L. Chitosan in nasal delivery systems for therapeutic drugs. J Control Release. 2014;190:189–200.
  • Amidi M, Romeijn SG, Borchard G, et al. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J Control Release. 2006;111:107–116.
  • Werle M, Bernkop‐Schnürch A. Thiolated chitosans: useful excipients for oral drug delivery. J Pharm Pharmacol. 2008;60:273–281.
  • Wu W, Yan L, Wu Q, et al. Evaluation of the toxicity of graphene oxide exposure to the eye. Nanotoxicology. 2016;10:1329–1340.
  • Wu W, Yan L, Chen S, et al. Investigating oxidation state-induced toxicity of PEGylated graphene oxide in ocular tissue using gene expression profiles. Nanotoxicology. 2018;1–17.
  • Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res Technol. 2008;14:249–260.
  • Amjadi M, Sheykhansari S, Nelson BJ, et al. Recent advances in wearable transdermal delivery systems. Adv Mater. 2018;30:1704530.
  • Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261.
  • He W, Guo X, Xiao L, et al. Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers. Int J Pharm. 2009;382:234–243.
  • Thein‐Han WW, Stevens WF. Transdermal delivery controlled by a chitosan membrane. Drug Dev Ind Pharm. 2004;30:397–404.
  • Thacharodi D, Rao KP. Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride. Biomaterials. 1995;16:145–148.
  • Teodorescu F, Queniat G, Foulon C, et al. Transdermal skin patch based on reduced graphene oxide: A new approach for photothermal triggered permeation of ondansetron across porcine skin. J Control Release. 2017;245:137–146.
  • Justin R, Román S, Chen D, et al. Biodegradable and conductive chitosan–graphene quantum dot nanocomposite microneedles for delivery of both small and large molecular weight therapeutics. RSC Adv. 2015;5:51934–51946.
  • Shi Y, Li L. Current advances in sustained-release systems for parenteral drug delivery. Expert Opin Drug Deliv. 2005;2:1039–1058.
  • Larsen C, Larsen SW, Jensen H, et al. Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opin Drug Deliv. 2009;6:1283–1295.
  • Mao S, Guo C, Shi Y, et al. Recent advances in polymeric microspheres for parenteral drug delivery–part 1. Expert Opin Drug Deliv. 2012;9:1161–1176.
  • Zhang C, Qu G, Sun Y, et al. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci. 2008;33:415–423.
  • Lv O, Tao Y, Qin Y, et al. Highly fluorescent and morphology-controllable graphene quantum dots-chitosan hybrid xerogels for in vivo imaging and pH-sensitive drug carrier. Mater Sci Eng C. 2016;67:478–485.
  • Anand P, Kunnumakara AB, Sundaram C, et al. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008;25:2097–2116.
  • Iwamoto T. Clinical application of drug delivery systems in cancer chemotherapy: review of the efficacy and side effects of approved drugs. Biol Pharm Bull. 2013;36:715–718.
  • Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localised cancer therapy. J Control Release. 2008;126:205–216.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
  • Liu D, Auguste DT. Cancer targeted therapeutics: from molecules to drug delivery vehicles. J Control Release. 2015;219:632–643.
  • Peer D, Karp JM, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2:751.
  • Kwon IK, Lee SC, Han B, et al. Analysis on the current status of targeted drug delivery to tumors. J Control Release. 2012;164:108–114.
  • Babu A, Ramesh R. Multifaceted applications of chitosan in cancer drug delivery and therapy. Mar Drugs. 2017;15:96.
  • Prusty K, Swain SK. Nanostructured chitosan composites for cancer therapy: A review. Int J Polym Mater Polym Biomater. 2017;67:879–888.
  • Suarato G, Li W, Meng Y. Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: a review. Biointerphases. 2016;11:04B201.
  • Arias JL, Reddy LH, Couvreur P. Fe 3 O 4/chitosan nanocomposite for magnetic drug targeting to cancer. J Mater Chem. 2012;22:7622–7632.
  • Cross D, Burmester JK. Gene therapy for cancer treatment: past, present and future. Clin Med Res. 2006;4:218–227.
  • Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv Biomed Res. 2012;1:27–43.
  • Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. 2010;62:12–27.
  • Zaharoff DA, Hoffman BS, Hooper HB, et al. Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12. Cancer Res. 2009;69:6192–6199.
  • Petrovsky N, Cooper PD. Carbohydrate-based immune adjuvants. Expert Rev Vaccines. 2011;10:523–537.
  • Zaharoff DA, Rogers CJ, Hance KW, et al. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine. 2007;25:2085–2094.
  • Yang K, Feng L, Liu Z. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv Drug Deliv Rev. 2016;105:228–241.
  • Ma N, Liu J, He W, et al. Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy. J Colloid Interface Sci. 2017;490:598–607.
  • Lv Y, Tao L, Bligh SA, et al. Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. Mater Sci Eng C. 2016;59:652–660.
  • Bai -Y-Y, Zheng S, Zhang L, et al. Non-invasively evaluating therapeutic response of nanorod-mediated photothermal therapy on tumor angiogenesis. J Biomed Nanotechnol. 2014;10:3351–3360.
  • Li M, Yang X, Ren J, et al. Using graphene oxide high near‐infrared absorbance for photothermal treatment of Alzheimer’s disease. Adv Mater. 2012;24:1722–1728.
  • Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380.
  • Li Y, Dong H, Li Y, et al. Graphene-based nanovehicles for photodynamic medical therapy. Int J Nanomedicine. 2015;10:2451.
  • Sahu A, Choi WI, Lee JH, et al. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials. 2013;34:6239–6248.
  • Yi L, Zhang Y, Shi X, et al. Recent progress of functionalised graphene oxide in cancer therapy. J Drug Target. 2018;1–20.
  • Nurunnabi M, Khatun Z, Reeck GR, et al. Photoluminescent graphene nanoparticles for cancer phototherapy and imaging. ACS Appl Mater Interfaces. 2014;6:12413–12421.
  • Li J-L, Tang B, Yuan B, et al. A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials. 2013;34:9519–9534.
  • Yan T, Zhang H, Huang D, et al. Chitosan-functionalized graphene oxide as a potential immunoadjuvant. Nanomaterials. 2017;7:59.
  • Liu Y, Dong X, Chen P. Biological and chemical sensors based on graphene materials. Chem Soc Rev. 2012;41:2283–2307.
  • He Q, Wu S, Yin Z, et al. Graphene-based electronic sensors. Chem Sci. 2012;3:1764–1772.
  • Shan C, Yang H, Han D, et al. Graphene/AuNPs/chitosan nanocomposites film for glucose biosensing. Biosens Bioelectron. 2010;25:1070–1074.
  • Ren J, Shi W, Li K, et al. Ultrasensitive platinum nanocubes enhanced amperometric glucose biosensor based on chitosan and nafion film. Sens Actuators B Chem. 2012;163:115–120.
  • Khun K, Ibupoto ZH, Lu J, et al. Potentiometric glucose sensor based on the glucose oxidase immobilized iron ferrite magnetic particle/chitosan composite modified gold coated glass electrode. Sens Actuators B Chem. 2012;173:698–703.
  • Singh A, Sinsinbar G, Choudhary M, et al. Graphene oxide-chitosan nanocomposite based electrochemical DNA biosensor for detection of typhoid. Sens Actuators B Chem. 2013;185:675–684.
  • Wang L, Zheng Y, Lu X, et al. Dendritic copper-cobalt nanostructures/reduced graphene oxide-chitosan modified glassy carbon electrode for glucose sensing. Sens Actuators B Chem. 2014;195:1–7.
  • Wei L, Fan Y-J, Wang -H-H, et al. Electrochemically shape-controlled synthesis in deep eutectic solvents of Pt nanoflowers with enhanced activity for ethanol oxidation. Electrochim Acta. 2012;76:468–474.
  • Liu A, Ren Q, Xu T, et al. Morphology-controllable gold nanostructures on phosphorus doped diamond-like carbon surfaces and their electrocatalysis for glucose oxidation. Sens Actuators B Chem. 2012;162:135–142.
  • Wang L, Fu J, Hou H, et al. A facile strategy to prepare Cu2O/Cu electrode as a sensitive enzyme-free glucose sensor. Int J Electrochem Sci. 2012;7:12587–12600.
  • Huang J, Dong Z, Li Y, et al. High performance non-enzymatic glucose biosensor based on copper nanowires–carbon nanotubes hybrid for intracellular glucose study. Sens Actuators B Chem. 2013;182:618–624.
  • Zheng JY, Quan ZL, Song G, et al. Vertical cobalt dendrite array films: electrochemical deposition and characterization, glucose oxidation and magnetic properties. J Mater Chem. 2012;22:12296–12304.
  • Liu Z, Huang L, Zhang L, et al. Electrocatalytic oxidation of d-glucose at nanoporous Au and Au–ag alloy electrodes in alkaline aqueous solutions. Electrochim Acta. 2009;54:7286–7293.
  • Liu D, Luo Q, Zhou F. Nonenzymatic glucose sensor based on gold–copper alloy nanoparticles on defect sites of carbon nanotubes by spontaneous reduction. Synth Met. 2010;160:1745–1748.
  • Mahshid SS, Mahshid S, Dolati A, et al. Template-based electrodeposition of Pt/Ni nanowires and its catalytic activity towards glucose oxidation. Electrochim Acta. 2011;58:551–555.
  • Yang P, Jin SY, Xu QZ, et al. Decorating PtCo bimetallic alloy nanoparticles on graphene as sensors for glucose detection by catalyzing luminol chemiluminescence. Small. 2013;9:199–204.
  • Li C, Wang H, Yamauchi Y. Electrochemical deposition of mesoporous Pt–Au alloy films in aqueous surfactant solutions: towards a highly sensitive amperometric glucose sensor. Chemistry. 2013;19:2242–2246.
  • Bertoncello P, Forster RJ. Nanostructured materials for electrochemiluminescence (ECL)-based detection methods: recent advances and future perspectives. Biosens Bioelectron. 2009;24:3191–3200.
  • Miao W. Electrogenerated chemiluminescence and its biorelated applications. Chem Rev. 2008;108:2506–2553.
  • Jie G-F, Liu P, Zhang -S-S. Highly enhanced electrochemiluminescence of novel gold/silica/CdSe-CdS nanostructures for ultrasensitive immunoassay of protein tumor marker. Chem Comm. 2010;46:1323–1325.
  • Liu X, Ju H. Coreactant enhanced anodic electrochemiluminescence of CdTe quantum dots at low potential for sensitive biosensing amplified by enzymatic cycle. Anal Chem. 2008;80:5377–5382.
  • Shan Y, Xu -J-J, Chen H-Y. Electrochemiluminescence quenching by CdTe quantum dots through energy scavenging for ultrasensitive detection of antigen. Chem Comm. 2010;46:5079–5081.
  • Jie G, Li L, Chen C, et al. Enhanced electrochemiluminescence of CdSe quantum dots composited with CNTs and PDDA for sensitive immunoassay. Biosens Bioelectron. 2009;24:3352–3358.
  • Li LL, Liu KP, Yang GH, et al. Fabrication of graphene–quantum dots composites for sensitive electrogenerated chemiluminescence immunosensing. Adv Funct Mater. 2011;21:869–878.
  • Deng S, Lei J, Cheng L, et al. Amplified electrochemiluminescence of quantum dots by electrochemically reduced graphene oxide for nanobiosensing of acetylcholine. Biosens Bioelectron. 2011;26:4552–4558.
  • Wang Y, Lu J, Tang L, et al. Graphene oxide amplified electrogenerated chemiluminescence of quantum dots and its selective sensing for glutathione from thiol-containing compounds. Anal Chem. 2009;81:9710–9715.
  • Wang T, Zhang S, Mao C, et al. Enhanced electrochemiluminescence of CdSe quantum dots composited with graphene oxide and chitosan for sensitive sensor. Biosens Bioelectron. 2012;31:369–375.
  • Winter M, Brodd RJ. What are batteries, fuel cells, and supercapacitors? ACS Publications; 2004;104:4245–4269.
  • Zhu Y, Murali S, Stoller MD, et al. Carbon-based supercapacitors produced by activation of graphene. Science. 2011;332:1537–1541.
  • Dubal DP, Holze R. Synthesis, properties, and performance of nanostructured metal oxides for supercapacitors. Pure Appl Chem. 2014;86:611–632.
  • Mastragostino M, Arbizzani C, Soavi F. Conducting polymers as electrode materials in supercapacitors. Solid State Ion. 2002;148:493–498.
  • Choi H-J, Jung S-M, Seo J-M, et al. Graphene for energy conversion and storage in fuel cells and supercapacitors. Nano Energy. 2012;1:534–551.
  • An C, Wang Y, Li L, et al. Effects of highly crumpled graphene nanosheets on the electrochemical performances of pseudocapacitor electrode materials. Electrochim Acta. 2014;133:180–187.
  • Chen P, Yang -J-J, Li -S-S, et al. Hydrothermal synthesis of macroscopic nitrogen-doped graphene hydrogels for ultrafast supercapacitor. Nano Energy. 2013;2:249–256.
  • Lee JW, Ko JM, Kim J-D. Hydrothermal preparation of nitrogen-doped graphene sheets via hexamethylenetetramine for application as supercapacitor electrodes. Electrochim Acta. 2012;85:459–466.
  • Olejniczak A, Lezanska M, Wloch J, et al. Novel nitrogen-containing mesoporous carbons prepared from chitosan. ?J Mater Chem A. 2013;1:8961–8967.
  • Primo A, Atienzar P, Sanchez E, et al. From biomass wastes to large-area, high-quality, N-doped graphene: catalyst-free carbonization of chitosan coatings on arbitrary substrates. Chem Comm. 2012;48:9254–9256.
  • Sun G, Li B, Ran J, et al. Three-dimensional hierarchical porous carbon/graphene composites derived from graphene oxide-chitosan hydrogels for high performance supercapacitors. Electrochim Acta. 2015;171:13–22.
  • Hao P, Zhao Z, Leng Y, et al. Graphene-based nitrogen self-doped hierarchical porous carbon aerogels derived from chitosan for high performance supercapacitors. Nano Energy. 2015;15:9–23.
  • Shannon MA, Bohn PW, Elimelech M, et al. Science and technology for water purification in the coming decades. Nature. 2008;452:301.
  • Greenlee LF, Lawler DF, Freeman BD, et al. Reverse osmosis desalination: water sources, technology, and today’s challenges. Water Res. 2009;43:2317–2348.
  • Babel S, Kurniawan TA. Low-cost adsorbents for heavy metals uptake from contaminated water: a review. J Hazard Mater. 2003;97:219–243.
  • Crini G. Non-conventional low-cost adsorbents for dye removal: a review. Bioresour Technol. 2006;97:1061–1085.
  • Soylak M, Unsal YE, Kizil N, et al. Utilization of membrane filtration for preconcentration and determination of Cu (II) and Pb (II) in food, water and geological samples by atomic absorption spectrometry. Food Chem Toxicol. 2010;48:517–521.
  • Karbassi A, Nadjafpour S. Flocculation of dissolved Pb, Cu, Zn and Mn during estuarine mixing of river water with the Caspian Sea. Environ Pollut. 1996;93:257–260.
  • Parida SK, Dash S, Patel S, et al. Adsorption of organic molecules on silica surface. Adv Colloid Interface Sci. 2006;121:77–110.
  • Lin T-F, Wu J-K. Adsorption of arsenite and arsenate within activated alumina grains: equilibrium and kinetics. Water Res. 2001;35:2049–2057.
  • Hua M, Zhang S, Pan B, et al. Heavy metal removal from water/wastewater by nanosized metal oxides: a review. J Hazard Mater. 2012;211:317–331.
  • Ren X, Chen C, Nagatsu M, et al. Carbon nanotubes as adsorbents in environmental pollution management: a review. Chem eng j. 2011;170:395–410.
  • Wang S, Sun H, Ang H-M, et al. Adsorptive remediation of environmental pollutants using novel graphene-based nanomaterials. Chem eng j. 2013;226:336–347.
  • Mauter MS, Elimelech M. Environmental applications of carbon-based nanomaterials. Environ Sci Technol. 2008;42:5843–5859.
  • Ramesha G, Kumara AV, Muralidhara H, et al. Graphene and graphene oxide as effective adsorbents toward anionic and cationic dyes. J Colloid Interface Sci. 2011;361:270–277.
  • Crini G. Recent developments in polysaccharide-based materials used as adsorbents in wastewater treatment. Prog Polym Sci. 2005;30:38–70.
  • Crini G, Badot P-M. Application of chitosan, a natural aminopolysaccharide, for dye removal from aqueous solutions by adsorption processes using batch studies: A review of recent literature. Prog Polym Sci. 2008;33:399–447.
  • Guibal E. Interactions of metal ions with chitosan-based sorbents: a review. Sep Purif Technol. 2004;38:43–74.
  • Chiou M, Li H. Adsorption behavior of reactive dye in aqueous solution on chemical cross-linked chitosan beads. Chemosphere. 2003;50:1095–1105.
  • Chen Y, Chen L, Bai H, et al. Graphene oxide–chitosan composite hydrogels as broad-spectrum adsorbents for water purification? J Mater Chem A. 2013;1:1992–2001.
  • Fan L, Luo C, Sun M, et al. Highly selective adsorption of lead ions by water-dispersible magnetic chitosan/graphene oxide composites. Colloids Surf B Biointerfaces. 2013;103:523–529.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.